Discoveries help bone marrow transplant recipients

8099 https://stemcell.keck.usc.edu/why-multipotent-progenitor-cells-matter/
Story Headline and Deck – USC News *
Why multipotent progenitor cells matter for patients receiving bone marrow transplants
Body Copy *
When patients receive bone marrow transplants, they are infused with complex admixtures of many different cell types with the power to regenerate their blood and immune systems. In a new study in Experimental & Molecular Medicine, scientists from the USC Stem Cell laboratory of Rong Lu share new discoveries about the influence of multipotent progenitor cells (MPPs) that are co-transplanted along with stem cells during bone marrow transplants.

“This is the first study to investigate the influence of MPPs, which we found stimulated stem cells to produce more T cells,” said Lu, the study’s corresponding author and an associate professor of stem cell biology, biomedical engineering, medicine, and gerontology at USC. “Improving T cell production in bone marrow transplantation can help prevent infections, a major complication that can be fatal for patients undergoing this treatment.”

In the study, first author Zheng Wang and his colleagues used genetic labels to “barcode” individual stem cells in bone marrow transplants in mice. The bone marrow transplants included MPPs along with blood-forming or “hematopoietic” stem cells (HSCs)–similar to what patients receive when being given bone marrow transplants to treat leukemia or other life-threatening conditions.

The scientists then tracked the blood production of the barcoded HSCs over a short-term period of 2.5 months and a long-term period of 6.5 months. When co-transplanted with MPPs, the HSCs produced many different cell types in the short-term, but ultimately increased their production of T cells in the long-term.

“The more we learn about these cellular interactions, the more we can inform clinicians about how to optimize bone marrow transplants for patients,” said Lu.

Additional co-authors include Du Jiang, Mary Vergel-Rodriguez, and Anna Nogalska from the Lu Lab.

The research was funded by the Chongqing Natural Science Foundation (cstc2019jcyj-msxmX0421), National Institutes of Health (R00-HL113104, R01HL135292, R01HL138225, and R35HL150826). Rong Lu is a scholar of the Leukemia & Lymphoma Society (LLS-1370-20) and was a Richard N. Merkin Assistant Professor.

The post Discoveries help bone marrow transplant recipients appeared first on USC News.

Graphic novel puts prescription opioid addiction in the spotlight

8091
URL of story on your school/unit website *

New Graphic Novel Heightens Awareness of Prescription Opioid Addiction

Story Headline and Deck – USC News *
New Graphic Novel Heightens Awareness of Prescription Opioid Addiction
Body Copy *
“Jackie’s Pain,” the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences’ latest health literacy publication, explains the risks of prescription opioid addiction.

The comic-book-style graphic novel is the 11th publication in the popular health literacy series created by longtime faculty member Mel Baron, PharmD ’57, and producer Gregory B. Molina, combining health information with dramatic storytelling and illustrations. Published in both Spanish and English, the booklet was designed to be distributed in the community at safety-net clinics, health fairs, pharmacies and other locations.

It tells the story of Jackie, whose adult son Luis becomes addicted to opioids after finding old prescription painkillers that Jackie had not discarded after recovering from knee surgery.

Jackie begins going to a support group for parents of addicted children as well as meditating to manage stress. She learns how to use naloxone in case her son has another overdose, and encourages him to try a support group.

Written and directed by Gabriela Lopez de Dennis, illustrated by Los Angeles graphic design firm TinyTeam LLC and designed by Soap Studio Inc., the graphic novel covers fentanyl, sharing opioids prescribed by a doctor, and how to safely dispose of unused or expired opioids. It also addresses what naloxone is and how to use it, getting help for opioid use disorder, and safer ways to get relief from pain.

Timely information about drug-related dangers

The graphic novel comes at a time when the number of drug overdose deaths has quintupled since 1999, and increased by nearly 30% from 2019 to 2020, according to the Centers for Disease Control and Prevention. Nearly 75% of the 91,799 drug overdose deaths in 2020 involved an opioid.

“We hear a lot of questions from parents about what to look for as far as opioid addiction and the booklets are extremely well made,” says Elaine Di Simone, outpatient/substance use disorder program director at Clinica Romero, a federally qualified health center where trained community leaders called promotoras are distributing the publication to local, at-risk populations. “These are very helpful for our parents of our youth program.”

Numerous experts on pain management and addiction, preventive medicine and health literacy–including Baron, Jennifer B. Unger, PhD, Siddarth Puri, MD, Aurora Geysimonyan, MPH, Edward Padilla, Melissa Durham, PharmD and Gene Lang, PharmD–served as script consultants.

“Especially today with so much misinformation, we want the appropriate information to reach the public,” Baron says. “Packing expert advice in an entertaining format helps ensure the public health message gets through. Our graphic novels fulfill a vital need by reaching underserved communities and educating patients about drug-related dangers. It’s part of what pharmacy is all about.”

The project was supported by the USC Mann School, UniHealth Foundation, USC Good Neighbors Campaign, L.A. CARE Health Plan, Keck Medicine of USC, and Beit T’Shuvah, a residential addiction recovery center whose leadership, staff and clients provided insights and contributions to the development of the publication.

The post Graphic novel puts prescription opioid addiction in the spotlight appeared first on USC News.

How to rewind the clock on arthritic cartilage

8097 https://stemcell.keck.usc.edu/rewind-clock-on-arthritic-cartilage/
Story Headline and Deck – USC News *
How to rewind the clock on arthritic cartilage … stat!
Body Copy *
A new study in Aging Cell describes how a key protein, called Signal Transducer and Activator of Transcription 3 (STAT3), might turn back the clock on aging cartilage that leads to osteoarthritis.

“STAT3 performs an astonishing repertoire of roles in development and regeneration, as well as inflammatory disease and cancer. In this study, we found an innovative chemical approach for reversing aging of joint-forming cells in a clinically relevant manner, because this intervention is simple and fully controlled,” said the study’s co-corresponding author Denis Evseenko, who is an Professor of Orthopaedic Surgery, and Stem Cell Biology and Regenerative Medicine at USC, and holds the J. Harold and Edna LaBriola Chair in Genetic Orthopedic Research.

“We wanted to understand the role of STAT3 in cartilage cells during embryonic development as well as in the context of osteoarthritis,” said co-corresponding author Steve Horvath, a Professor of Human Genetics and Biostatstics at UCLA.

To accomplish this, first authors Arijita Sarkar, Nancy Q. Liu and their colleagues at USC and UCLA performed a series of experiments to uncover how STAT3 turns genes on and off through a process known as epigenetic regulation. Specifically, the team identified patterns of epigenetic regulation that correlate with the age of cartilage cells. These correlations served as the basis for creating what the researchers dubbed an “epigenetic clock” for cartilage cells.

By using a molecule to activate STAT3, they were able to reverse the hands of the epigenetic clock–turning on many genes and creating an epigenetic pattern typical of younger cartilage cells. When they genetically inactivated STAT3, the epigenetic clock ticked faster–turning off many genes and promoting an epigenetic pattern observed in older cartilage cells.

The scientists then focused their attention on an important enzyme called DNA methyltransferase 3 beta (DNMT3B), which interacts with STAT3. When STAT3 was inactivated, DNMT3B kicked into high gear to add aging marks to the DNA molecule, and promoted the progression of knee osteoarthritis in injured mice.

In the arthritic knee cartilage of the mice, there was a significant population of cartilage cells that appeared to be turning back time and reverting to an immature state.

“These cells may be assuming more embryonic-like state as an attempt to enhance their capacity to develop new knee cartilage,” said Sarkar, who is a postdoc in the Evseenko Lab.

Unfortunately, while these immature cells make cartilage that is youthfully regenerative during embryonic development or acute injury, they seemed to create cartilage that is dysfunctionally immature in the context of a chronic condition such as osteoarthritis.

“When present on a longer term basis, hyperactivation of the immature program in cartilage cells is likely to promote inflammation and, ultimately, degeneration and fibrosis,” said Liu, a senior scientist in the Evseenko Lab.

In the future, the results of this study can inform the quest to develop treatments that harness STAT3’s power to promote regeneration without tapping into its tendency to trigger inflammation.

Additional co-authors include Jenny Magallanes, Jade Tassey, Siyoung Lee, Ruzanna Shkhyan, Youngjoo Lee, Jinxiu Lu, Yuxin Ouyang, Hanhan Tang, Fangzhou Bian, Litao Tao, and Neil Segil from USC, and Jason Ernst and Karen M. Lyons from UCLA.

This work was supported by grants from the National Institutes of Health (R01AR071734 and R01AG058624), Department of Defense (W81XWH-13-1-0465), and the California Institute for Regenerative Medicine (TRAN1- 09288).

The post How to rewind the clock on arthritic cartilage appeared first on USC News.

How USC-led innovation can solve global challenges

With nearly $1 billion in actively funded research, USC is among the nation’s leading institutions for innovative, impactful discovery. Leading that effort is Ishwar Puri, who arrived at USC in 2021 and was recently promoted to senior vice president for research and innovation.

In the two years since his arrival, the university has continued to build on its research successes, winning major federal grants for research and innovation in computing, biomedical device and drug therapy development, medical research, as well as collaborative research projects with local governments and organizations that solve social problems and policy issues.

Puri has been charged with increasing interdisciplinary partnerships and speeding up discovery in an era of increasingly tech-dependent, rapid scientific inquiry. We spoke with the internationally recognized scientist and engineer about some of the past year’s major accomplishments, what might be in store for 2023 and how USC-led innovation can solve global challenges.

Congratulations on your new title. The most notable change is the addition of innovation under the umbrella of research. What does that new area of focus represent, practically?

Thank you, but really the story isn’t about me — it’s about USC President Carol L. Folt’s vision for the university since she arrived. During her time at USC, our sponsored research has increased at 7% annually, which would put us close to doubling that figure by 2028 or so. Money isn’t everything; it is trumped by impact. So, Dr. Folt has asked us to work toward audacious moonshots in areas such as computing and health. She has tasked us with improving our impact on society by developing innovative solutions for complex problems.

Money isn’t everything; it is trumped by impact.

Ishwar Puri

Innovation can take many forms. It can be through entrepreneurship, licensing to corporate entities and also thinking in a different way. If you think of sustainability, it’s not just about climate change research or providing solutions for electrification or other forms of renewable energy. Sustainability is about finding the kind of human solutions that will take us away from fossil fuel consumption. It’s finding environmentally friendly ways to eliminate or reduce waste. These are human problems, social science problems, health problems. That is where innovation comes in.

Practically, we are developing a partnership model of innovation and entrepreneurship. We are working with all our schools to help each of them flourish. We help them take their best examples and accelerate these through central means, including the Alfred E. Mann Institute, which is now part of the Office of Research and Innovation.

You mentioned an emphasis on research and innovation that is impactful. What are some examples of USC research that made an impact in 2022?

Due to the depth and breadth of expertise at USC, researchers across the university conduct impactful research every day. One example is our world-leading work in Alzheimer’s disease research. Publications (such as a recent one from Paul Thompson, Arthur Toga and Julie Zissimopoulos) have greatly expanded our collective knowledge of the causes and potential solutions for neurodegenerative cognitive diseases. In other areas, Kristina Lerman and Emilio Ferrara from the USC Information Sciences Institute examined the effects of polarization on social media users. Gale Sinatra co-authored a piece for The Conversation that examined how Hollywood perpetuates myths that fuel science skepticism. And earlier this year, Sergey Nuzhdin partnered with AltaSea at the Port of Los Angeles to open a massive 6,000-square-foot seaweed lab that will help grow the blue economy. These are just a few examples; there are countless others.

How is USC looking to expand its impact in 2023?

The president’s view is that if we’re really going to have an impact, it must be through partnerships. USC has very strong local community partnerships in environmental health, for instance. We’ve also started to form partnerships with area universities, notably with UCLA and Caltech, on grant proposals that combine the strengths of each institution to address complex challenges. In fact, USC is the lead partner of the new National Science Foundation Innovation Corps Hub: West Region, a consortium of engineers and scientists from top research universities in the Western United States. And because we are committed to developing a diverse talent pipeline, we are partnering with minority-serving institutions and community colleges through outreach activities and other partnerships. The president has insisted on and successfully developed a culture of collaboration among university leaders.

That emphasis on collaboration applies within the university as well?

Yes. Take entrepreneurship for example. When you think of entrepreneurship in the university setting, you typically think of the classic tech transfer model: Do some research, and then commercialize it. But the real talent at USC lies in the sheer number of our potential entrepreneurs. We have business-minded undergraduate and graduate students, postdocs and faculty members, and to support them we must meld research with experiential learning, where different parts of the university come together.

We do amazing discovery research. But maybe it’s not just the researcher who takes that work to fruition as a solution. Instead, it is a partnership with students, postdocs and others.

Ishwar Puri

We do amazing discovery research. But maybe it’s not just the researcher who takes that work to fruition as a solution. Instead, it is a partnership with students, postdocs and others. In partnership with the provost and the senior vice president for health sciences, the Office of Research and Innovation now works with deans to develop programs that take advantage of internal partnerships in different areas of the university. We cannot afford to segment or sector different areas because they are synergistic. The future lies in partnership and collaboration.

Speaking of the future, if you were a young researcher, why would you want to be at USC?

It really comes down to three things: excellence, scale and opportunity. Undoubtedly, USC offers excellence and hence we are a great attractor of talent. USC also offers scale. Where else in the world can one go to collaborate with leading scholars in communications, technology and cinematic arts? Not many other places. That school of schools model, and the scales of those schools, coupled with our excellence in health sciences, technology, humanities and the arts is a great launch pad for a young person’s career. In addition, the president’s expansive research vision for the university — increased partnerships; investments in internal support programs like internal grants, startups and mentoring; and her moonshots — provides young researchers with incredible opportunities to rub shoulders with experienced academics who have been in the business for a while and contributes to everyone’s success.

These all combine to make USC a very exciting place to work. I feel very fortunate to have the opportunity to be at USC and work with brilliant researchers across disciplines. This truly is an exceptional place with unrivaled talent and leadership.

The post How USC-led innovation can solve global challenges appeared first on USC News.

How old is your brain, really? Artificial intelligence knows

The human brain holds many clues about a person’s long-term health — in fact, research shows that a person’s brain age is a more useful and accurate predictor of health risks and future disease than their birthdate. A new artificial intelligence model that analyzes MRI brain scans developed by USC researchers could be used to accurately capture cognitive decline linked to neurodegenerative diseases like Alzheimer’s much earlier than previous methods.

Brain aging is considered a reliable biomarker for neurodegenerative disease risk. Such risk increases when a person’s brain exhibits features that appear “older” than expected for someone of that person’s age. By tapping into the deep learning capability of the team’s novel AI model to analyze the scans, the researchers can detect subtle brain anatomy markers that are otherwise very difficult to detect and that correlate with cognitive decline. Their findings, recently published in the journal Proceedings of the National Academy of Sciences, offer an unprecedented glimpse into human cognition.

“Our study harnesses the power of deep learning to identify areas of the brain that are aging in ways that reflect a cognitive decline that may lead to Alzheimer’s,” said Andrei Irimia, assistant professor of gerontology, biomedical engineering and neuroscience at the USC Leonard Davis School of Gerontology and corresponding author of the study.

People age at different rates, and so do tissue types in the body. We know this colloquially when we say, ‘So-and-so is 40, but looks 30.’

Andrei Irimia, USC Leonard Davis
School of Gerontology

“People age at different rates, and so do tissue types in the body,” Irimia said. “We know this colloquially when we say, ‘So-and-so is 40, but looks 30.’ The same idea applies to the brain. The brain of a 40-year-old may look as ‘young’ as the brain of a 30-year-old, or as ‘old’ as that of a 60-year-old.”

Brain aging: A more accurate alternative to existing methods

Researchers collated the brain MRIs of 4,681 cognitively normal participants, some of whom went on to develop cognitive decline or Alzheimer’s disease later in life.

Using these data, they created an AI model called a neural network to predict participants’ ages from their brain MRIs. First, the researchers trained the network to produce detailed anatomic brain maps that reveal subject-specific patterns of aging. They then compared the perceived (biological) brain ages with the actual (chronological) ages of study participants. The greater the difference between the two, the worse the participants’ cognitive scores, which reflect Alzheimer’s risk.

The results show that the team’s model can predict the true (chronological) ages of cognitively normal participants with an average absolute error of 2.3 years, which is about one year more accurate than an existing, award-winning model for brain age estimation that used a different neural network architecture.

“Interpretable AI can become a powerful tool for assessing the risk for Alzheimer’s and other neurocognitive diseases,” said Irimia, who also holds faculty positions with the USC Viterbi School of Engineering and the USC Dornsife College of Letters, Arts and Sciences.

“The earlier we can identify people at high risk for Alzheimer’s disease, the earlier clinicians can intervene with treatment options, monitoring and disease management.“

Brain aging: differences according to sex

The new model also reveals sex-specific differences in how aging varies across brain regions. Certain parts of the brain age faster in males than in females, and vice versa.

Males, who are at higher risk of motor impairment due to Parkinson’s disease, experience faster aging in the brain’s motor cortex, an area responsible for motor function. Findings also show that, among females, typical aging may be relatively slower in the right hemisphere of the brain.

An emerging field of study shows promise for personalized medicine

Applications of this work extend far beyond disease risk assessment. Irimia envisions a world in which the novel deep learning methods developed as part of the study are used to help people understand how fast they are aging in general.

“One of the most important applications of our work is its potential to pave the way for tailored interventions that address the unique aging patterns of every individual,” Irimia said.

“Many people would be interested in knowing their true rate of aging. The information could give us hints about different lifestyle changes or interventions that a person could adopt to improve their overall health and well-being. Our methods could be used to design patient-centered treatment plans and personalized maps of brain aging that may be of interest to people with different health needs and goals.”

The post How old is your brain, really? Artificial intelligence knows appeared first on USC News.

Consumption of fast food linked to liver disease

8084
https://news.keckmedicine.org/consumption-of-fast-food-linked-to-liver-disease/
Story Headline and Deck – USC News *
Consumption of fast food linked to liver disease

Risk of liver damage is highest for those with obesity or diabetes
Body Copy *
LOS ANGELES — The new year has begun, and with it, resolutions for change.
A study from Keck Medicine of USC published today in Clinical Gastroenterology and Hepatology gives people extra motivation to reduce fast-food consumption.
The study found that eating fast food is associated with nonalcoholic fatty liver disease, a potentially life-threatening condition in which fat builds up in the liver.
Researchers discovered that people with obesity or diabetes who consume 20% or more of their daily calories from fast food have severely elevated levels of fat in their liver compared to those who consume less or no fast food. And the general population has moderate increases of liver fat when one-fifth or more of their diet is fast food.
“Healthy livers contain a small amount of fat, usually less than 5%, and even a moderate increase in fat can lead to nonalcoholic fatty liver disease,” said Ani Kardashian, MD, a hepatologist with Keck Medicine and lead author of the study. “The severe rise in liver fat in those with obesity or diabetes is especially striking, and probably due to the fact that these conditions cause a greater susceptibility for fat to build up in the liver.”
While previous research has shown a link between fast food and obesity and diabetes, this is one of the first studies to demonstrate the negative impact of fast food on liver health, according to Kardashian.
The findings also reveal that a relatively modest amount of fast food, which is high in carbohydrates and fat, can hurt the liver. “If people eat one meal a day at a fast-food restaurant, they may think they aren’t doing harm,” said Kardashian. “However, if that one meal equals at least one-fifth of their daily calories, they are putting their livers at risk.”
Nonalcoholic fatty liver disease, also known as liver steatosis, can lead to cirrhosis, or scarring of the liver, which can cause liver cancer or failure. Liver steatosis affects over 30% of the U.S. population.
Kardashian and colleagues analyzed the most recent data from the nation’s largest annual nutritional survey, the 2017-2018 National Health and Nutrition Examination Survey, to determine the impact of fast-food consumption on liver steatosis.
The study characterized fast food as meals, including pizza, from either a drive-through restaurant or one without wait staff.
The researchers evaluated the fatty liver measurement of approximately 4,000 adults whose fatty liver measurements were included in the survey and compared these measurements to their fast-food consumption.
Of those surveyed, 52% consumed some fast food. Of these, 29% consumed one-fifth or more daily calories from fast food. Only this 29% of survey subjects experienced a rise in liver fat levels.
The association between liver steatosis and a 20% diet of fast food held steady for both the general population and those with obesity or diabetes even after data was adjusted for multiple other factors such as age, sex, race, ethnicity, alcohol use and physical activity.
“Our findings are particularly alarming as fast-food consumption has gone up in the last 50 years, regardless of socioeconomic status,” said Kardashian. “We’ve also seen a substantial surge in fast-food dining during the COVID-19 pandemic, which is probably related to the decline in full-service restaurant dining and rising rates of food insecurity. We worry that the number of those with fatty livers has gone up even more since the time of the survey.”
She hopes the study will encourage health care providers to offer patients more nutrition education, especially to those with obesity or diabetes who are at higher risk of developing a fatty liver from fast food. Currently, the only way to treat liver steatosis is through an improved diet.
Jennifer Dodge, MPH, assistant professor of research medicine and population and public health sciences at the Keck School of Medicine of USC and Norah Terrault, MD, MPH, a Keck Medicine gastroenterologist and division chief of gastroenterology and liver diseases at the Keck School, were also authors on the study.

###

For more information about Keck Medicine of USC, please visit news.KeckMedicine.org.

The post Consumption of fast food linked to liver disease appeared first on USC News.

Study shows how liver cancer hijacks circadian clock machinery inside cells

8082
https://keck.usc.edu/study-shows-how-liver-cancer-hijacks-circadian-clock-machinery-inside-cells/
Story Headline and Deck – USC News *
Study shows how liver cancer hijacks circadian clock machinery inside cells

Researchers from the Keck School of Medicine of USC are now one step closer to understanding how to halt the spread of the deadly disease in the body.
Body Copy *
The most common type of liver cancer, hepatocellular carcinoma (HCC), is already the third leading cause of cancer-related deaths globally–and cases are on the rise, both in the U.S. and worldwide. While chemotherapy, surgery and liver transplants can help some patients, targeted treatments for HCC could save millions more lives.

Recent studies have offered clues about one potential target: the circadian clock proteins inside cells, which help coordinate changes in the body’s functioning over the course of a day. But most of this research only hints at an indirect link between circadian clock function and HCC, for instance the observation that cells collected from patients with liver cancer have disrupted circadian rhythms.

Now, a study led by researchers at the Keck School of Medicine of USC not only directly links circadian clock proteins to liver cancer, but also shows precisely how cancer cells hijack circadian clock machinery to divide and spread. The research, just published in the journal Proceedings of the National Academy of Sciences, also found that inhibiting key clock proteins can prevent cancer cells from multiplying.

“Earlier studies didn’t give us a real handle on how we could use a specific treatment to target processes within liver cancer cells. In this paper, we’re making the first steps toward that,” said the study’s senior author, Steve A. Kay, PhD, University and Provost Professor of Neurology, Biomedical Engineering and Quantitative Computational Biology at the Keck School of Medicine of USC and director of the USC Michelson Center for Convergent Bioscience.

The research is a collaboration between cell biology experts and clinicians at the USC Norris Comprehensive Cancer Center, which is known for its leadership in clinical trials for various cancers, including HCC.

“We are very excited to find a new, innovative treatment strategy that may ultimately improve outcomes for patients with liver cancer,” said Heinz-Josef Lenz, MD, a professor of medicine and preventive medicine, associate director for clinical research and co-leader of the Gastrointestinal Cancers Program at USC Norris. “By targeting the circadian clock, we are not only targeting tumor cells but also the area around the tumor, which can help increase the efficacy of other targeted treatments.”

Interrupting the cell cycle

To elucidate the role of circadian clock proteins in HCC, Kay, Lenz and their colleagues conducted a series of experiments, using a combination of cell culture, genomic analysis and animal models.

First, the researchers showed that two key clock proteins, known as CLOCK and BMAL1, are critical for the replication of liver cancer cells in cell culture. When CLOCK and BMAL1 are suppressed, cancer cells’ replication process was interrupted–ultimately causing cell death, or apoptosis. Triggering apoptosis, during which a cell stops dividing, then self-destructs, is the goal of many modern cancer treatments.

Next, the team drew on their tool chest of genomic samples, built through years of research on circadian clock proteins in the body, to further understand the role of CLOCK and BMAL1. Among other findings, they showed that eliminating the clock proteins reduced levels of the enzyme Wee1 and increased levels of the enzyme inhibitor P21.

“That’s exactly what you want, because when it comes to cancer cell proliferation, P21 is a brake and Wee1 is a gas pedal,” said Kay, who also co-directs the USC Norris Center for Cancer Drug Development.

Finally, the researchers tested their findings in vivo. Mice injected with unmodified human liver cancer cells grew large tumors, but those injected with cells modified to suppress CLOCK and BMAL1 showed little to no tumor growth.

Developing targeted therapies

Understanding how cancer cells hijack circadian clock proteins is a big step toward halting the spread of liver cancer, but the researchers have more questions to answer. For example, Kay and his team hope to explore the relationship between circadian clock proteins, Wee1, and the P53 gene. The gene helps prevent the growth of tumors in the body, and mutations in P53 have long been linked with a heightened risk for various cancers.

“We really need to understand that relationship to better identify which patients might benefit most from a targeted therapy against CLOCK and BMAL1,” Kay said.

He and his team also hope to begin testing experimental drugs that can target CLOCK and BMAL1 in patients with liver cancer. The work is part of their larger body of research that analyzes circadian clock proteins in several types of cancer, including glioblastoma, leukemia and colorectal cancer.

About this study

In addition to Kay and Lenz, the study’s other authors are Meng Qu and Alexander Vu from the Department of Neurology, Keck School of Medicine of USC; Raymond Wu and Hidekazu Tsukamoto from the Department of Pathology, Keck School of Medicine of USC; Guoxin Zhang and Jeremy N. Rich from the Department of Neurology, University of Pittsburgh; Han Qu and Zhenyu Jia from the Department of Botany and Plant Sciences, University of California, Riverside; and Wendong Huang from the Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center.

This work was supported by the University of Southern California Norris Comprehensive Cancer Center Translational Team Accelerator Program; the National Institutes of Health [P30 CA047904, CA238662, CA197718, NS103434, CA139158, DK124627, P50 AA011999, U01 AA027681]; the United States Department of Agriculture National Institute of Food and Agriculture Grant [2019-67022-29930]; the Department of Veterans Affairs [5 I01BX001991]; and a Biomedical Laboratory Research and Development Research Career Scientist Award [5 IK6BX004205].

The post Study shows how liver cancer hijacks circadian clock machinery inside cells appeared first on USC News.

Study suggests a solution to the opioid epidemic: Tell doctors their patients fatally overdosed

8079
https://priceschool.usc.edu/news/opioid-overdose-nudge-study-jason-doctor-usc-price/
Story Headline and Deck – USC News *
USC study suggests one solution to America’s opioid epidemic: Tell doctors their patients fatally overdosed
Body Copy *
There are no simple solutions to America’s deadly drug overdose epidemic, which costs 100,000 lives each year and is erasing gains in life expectancy. But a team of USC researchers has found one low-cost intervention can make a difference: a letter notifying providers their patient has died from an overdose.
The team’s study, published today in JAMA Open Network, shows that notifying clinicians through an informational letter from their county’s medical examiner that a patient had suffered a fatal overdose reduced the number of opioid prescriptions they wrote for up to a year. The notification may also help physicians spot problematic use of legal and illicit drug use.
The study follows a 2018 report by the same team that found the same impact, but only had three months of data.
“Clinicians don’t necessarily know a patient they prescribed opioids to has suffered a fatal overdose,” said lead author Jason Doctor, chair of the Department of Health Policy and Management at the USC Sol Price School of Public Policy and co-director of the Behavioral Sciences Program at the USC Schaeffer Center for Health Policy & Economics. “We knew closing this information loop immediately reduced opioid prescriptions. Our latest study shows that change in prescribing behavior seems to stick.”
A simple public health intervention with a lasting impact
Doctor and his team sent letters to 809 clinicians–predominantly medical doctors–who had prescribed opioids to 166 people who had suffered fatal overdoses in San Diego County. The letter was intended to be informative and respectful in tone while providing information about safer prescribing. The researchers compared prescribing patterns among these clinicians to those who had not received the letter.
While there was a gradual reduction in opioid prescribing across the board, study authors found the rate of the reduction was faster and more robust among those who received the letter. The earlier study found that in the three months after receiving the letter, prescribing decreased by nearly 10% compared to the control group which didn’t receive a letter. The new study found that after one year, those who received the letter wrote 7% fewer prescriptions than clinicians who hadn’t received the notification.
“The new study shows this change is not just a temporary blip and then clinicians went back to their previous prescribing,” said Doctor. “This low-cost intervention has a long-lasting impact.”
Doctor acknowledged that attention to the number of deaths from drugs prescribed by clinicians has been eclipsed by the focus on rising deaths from illicit opioid use, particularly during the COVID-19 pandemic.
“The sad truth is, we never addressed the first problem of deaths from prescribed opioids. In fact, it’s all mixed together because nationally, approximately half of people who die of an illicit fentanyl drug overdose have also had an opioid prescription within the past year,” he explained.
Medical examiners are uniquely positioned to mitigate future opioid overdose deaths
The big takeaway, said Doctor, is the letters from the medical examiner provide a unique opportunity to communicate with physicians in the wake of overdose deaths to save lives from both legal and illegal opioids.
“The letter is a nudge to providers that the opioid epidemic is in their community and affecting their patients. It is easy to read the headlines and assume you are not part of the problem,” he said. “Doctors have an opportunity to talk to their patients and consider alternatives to opioids. I believe we can reach about half of the people in the illicit fentanyl epidemic through a doctor who has seen them.”
Doctor and other study authors are currently working with Los Angeles County to examine lessons from the research and looking at potential public policy interventions, including mandating such notifications from county medical examiners to clinicians.
About the study
Additional study authors include Emily Stewart and Tara Knight of the USC Schaeffer Center; Roneet Lev of the Scripps Mercy Hospital San Diego; Jonathan Lucas of the Department of Medical Examiner-Coroner of the County of Los Angeles; Andy Nguyen of Global Blood Therapeutics, South San Francisco; and Michael Menchine of the Department of Emergency Medicine at UCLA. The work was supported by the California Health Care Foundation (grant 19413) to Doctor, Stewart and Knight; the National Institute on Aging (NIA) at the National Institutes of Health (grants R21-AG057395-01 and R33-AG057395 to Knight); National Institute on Drug Abuse (R01 DA046226) and the NIA Roybal Center for Behavioral Interventions (P30AG024968 to Knight).

The post Study suggests a solution to the opioid epidemic: Tell doctors their patients fatally overdosed appeared first on USC News.

Study challenges previous ideas regarding Alzheimer’s disease

story on your school/unit website *

New study challenges previous ideas regarding Alzheimer’s disease

Story Headline and Deck – USC News *
New study challenges previous ideas regarding Alzheimer’s disease

Increase in amyloid beta protein in the brain, often thought to be directly involved in Alzheimer’s pathology, may instead be a general change that occurs with age even in healthy brains, says senior author Caleb Finch.

Body Copy *
A new USC Leonard Davis School of Gerontology study challenges existing ideas of how buildup of a protein called amyloid beta (A?) in the brain is related to Alzheimer’s disease.

While buildup of amyloid protein has been associated with Alzheimer’s-related neurodegeneration, little is known about how the protein relates to normal brain aging, said University Professor Caleb Finch, the study’s senior author and holder of the ARCO/William F. Kieschnick Chair in the Neurobiology of Aging at the USC Leonard Davis School.

To explore the levels of A? in human brains, the researchers analyzed tissue samples from both healthy brains and brains of patients with dementia. More severe Alzheimer’s cases were indicated by higher Braak staging scores, a measurement of how widely signs of Alzheimer’s pathology are found within the brain.

The analysis revealed that older, cognitively healthy brains showed similar amounts of dissolvable, non-fibrillar amyloid protein as brains of Alzheimer’s patients. But, as the researchers expected, the brains of Alzheimer’s patients had higher amounts of insoluble A? fibrils, the form of amyloid protein that aggregates to form the telltale “plaques” seen in the disease, said Max Thorwald, the study’s first author and a postdoctoral researcher at the USC Leonard Davis School.

The findings challenge the idea that simply having higher amounts of amyloid protein in general is an underlying cause of Alzheimer’s, say Finch and Thorwald. Instead, the increase in soluble A? may be a general aging-related change in the brain not specific to Alzheimer’s, while higher levels of fibrillary amyloid appear to be a better indicator of poorer brain health.

Rather than Alzheimer’s simply involving increased production of A? protein, the more important issue may be a reduced ability to effectively clear the protein and stave off the creation of plaque-contributing fibrillary amyloid, Thorwald said.

“These findings further support the use of aggregated, or fibrillary, amyloid as a biomarker for Alzheimer’s treatments,” Thorwald said. “The site in which amyloid processing occurs has less precursor and enzyme available for processing, which may suggest the removal of amyloid as a key issue during Alzheimer’s.”

Increases in amyloid levels happen during early adulthood and differ by brain region. Further studies, including those investigating drugs to possibly break down amyloid, should incorporate positron emission tomography (PET) imaging in both healthy individuals and Alzheimer’s patients of a wide range of ages to determine how and where amyloid processing and removal changes in the brain over time, he added.

“The brain’s frontal cortex has more amyloid production compared to the cerebellum during the aging process in human brains, which coincides with their Alzheimer’s-correlated pathologies in late life,” Thorwald said. “Future projects should examine amyloid over the life course in both cognitively normal and Alzheimer’s patients with both modulation of amyloid processing or removal of amyloid through monoclonal antibodies currently used in clinical trials for Alzheimer’s treatment.”

Monoclonal antibody treatment lemanecab has been observed to reduce A? plaques in clinical trials and recently received FDA approval for its potential to slow cognitive decline in Alzheimer’s patients, but the results warrant further careful research regarding long-term impact, Finch said.

“Lecanemab clearly works to diminish fibrillar amyloid,” he said. “However, we are concerned with major side effects, including brain swelling and bleeding, that were 100% more than in controls, with unknown delayed or latent impact.”

Learning more about how the brain processes and removes proteins such as A? could provide important insights into Alzheimer’s disease and its causes. Finch noted that very few cases of dementia occur with amyloid plaques, or masses of aggregated A? protein, as the only pathology present in affected patients’ brains. Instead, most cases present with more complicated tissue abnormalities, from buildup of additional types of protein to small bleeds in the brain: “The aging brain is a jungle.”

—

The study, “Amyloid futures in the expanding pathology of brain aging and dementia,” appeared online on December 19, 2022 in the journal Alzheimer’s and Dementia. Along with Finch and Thorwald, coauthors include Justine Silva and Elizabeth Head of the University of California, Irvine.

Thorwald was supported by National Institute on Aging (NIA) grant T32-AG000037, and Silva and Head were supported by NIA grant P30AG066519. Lab studies were supported by National Institutes of Health grants to Finch (R01-AG051521, P50-AG05142, and P01-AG055367). Brain specimens were obtained from Alzheimer’s Disease Research Center Tissue Cores at USC (P50-AG005142 and AG066530), UC Irvine (P30-AG066519), and University of Washington (P30-AG066509 and U01- AG006781).

The post Study challenges previous ideas regarding Alzheimer’s disease appeared first on USC News.

3% of kids have elevated sensory issues that seem to worsen through early childhood

https://chan.usc.edu/news/latest/study-finds-3-percent-of-children-have-elevated-sensory-issues-that-seemingly-worsen-throughout-early-childhood-a-pattern-strongly-linked-to-autism
Story Headline and Deck – USC News *
Study finds 3 percent of children have elevated sensory issues that seemingly worsen throughout early childhood, a pattern strongly linked to autism
Body Copy *
New results from a USC-led study reveal that 3 percent of all children have elevated sensory traits which seemingly worsen as they grow from infants/toddlers into school-aged children. Of those fitting the profile of this so-called “Elevated-All Worsening” group, 82 percent were diagnosed with autism or showed elevated autistic traits by the time they reached 3-6 years old.

The data demonstrate the strong association between children’s early sensory trajectories and later sensory challenges impacting their developmental and behavioral outcomes. Results were published online today in Development and Psychopathology.

“While every autistic child is unique, previous research suggests that autism has sensory subtypes — consistent patterns of over- and under-reactivity when it comes to sight, sound, touch and movement,” said the article’s lead author Yun-Ju Claire Chen PhD ’21. “These results not only show how sensory preferences shift throughout early childhood for all kids, but reveal particular patterns tied to various later clinical and behavioral outcomes.”

Chen is currently a postdoctoral research fellow at McMaster University in Ontario, Canada, and recently completed her PhD degree in Occupational Science at USC Chan.

For six years, as part of the North Carolina Child Development Survey project, researchers followed more than 1,500 children born in North Carolina in 2013. The researchers asked parents about their child’s sensory behaviors at three points during three developmental stages: as infants/toddlers (6-19 months old), as preschoolers (3-4 years old) and as school-aged children (6-7 years old). Parents were also asked about their child’s autistic symptoms, about various developmental concerns and whether or not their child had received any diagnoses.

Chen and colleagues studied a subset of 389 trajectories to better understand how the child’s sensory behaviors were perceived to change over time, and whether any of those change patterns were linked to clinical and adaptive/maladaptive outcomes as the child grew to be school-aged.

The researchers found that 62 percent of trajectories were generally stable or improved, with mild to moderate sensory features and some challenges in certain areas. They categorized 35 percent of trajectories as “Adaptive–All Improving,” with very low sensory concerns and overall better outcomes at school-age.

But 3 percent of children had an “Elevated–All Worsening” trajectory, characterized by highly elevated sensory features and dramatically worsening patterns over time, with significant challenges across behavioral domains at school age. 82 percent of “Elevated–All Worsening” children received an autism diagnosis or showed elevated autistic traits between 3-6 years old. The group is composed of significantly more boys and of children of parents who have lower educational attainment. Children meeting this group’s criteria also had a higher likelihood of an ADHD diagnosis or concerns, and significantly higher levels of emotional concerns such as anxiety.

Because the “Elevated–All Worsening” subtype could first be detected at the 6-19 month measuring point, the researchers say sensory features should be considered a useful early behavioral marker of autism and associated challenges later in life.

“This study confirms that early childhood sensory experiences are strongly associated with clinical and behavioral outcomes later in life,” said Associate Dean and Chair Grace Baranek, the article’s senior author.

Baranek directs the Innovations in Neurodevelopmental Sensory Processing Research lab — also known as the insp!re lab — at USC Chan.

Research Professor John Sideris, who is USC Chan’s director of instrument development and psychometric/statistical analysis, is also a co-author. Baranek’s longtime collaborators Linda Watson and Elizabeth Crais, investigators at the Program for Early Autism Research, Leadership and Service at the University of North Carolina at Chapel Hill, are also co-authors.

“By characterizing children according to their early sensory development, clinicians can more efficiently and accurately identify those who are more likely to experience developmental challenges once they reach school age,” Baranek said. “And as clinicians pay more and more attention to pediatric sensory traits as part of a holistic health profile, children at elevated likelihood of autism can be referred to critical services at earlier junctures in order to access interventions that can optimize their sensory skills and social participation in the long run,” Baranek said.

Learn more about the Innovations in Neurodevelopmental Sensory Processing Research (insp!re) lab at chan.usc.edu/inspirelab.

The post 3% of kids have elevated sensory issues that seem to worsen through early childhood appeared first on USC News.